NASDAQ:PLSE Pulse Biosciences (PLSE) Stock Price, News & Analysis $17.19 +0.02 (+0.12%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$17.19 0.00 (0.00%) As of 05/2/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Pulse Biosciences Stock (NASDAQ:PLSE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Pulse Biosciences alerts:Sign Up Key Stats Today's Range$17.13▼$18.0650-Day Range$14.48▼$19.3452-Week Range$6.66▼$25.00Volume170,533 shsAverage Volume198,563 shsMarket Capitalization$1.16 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.Read More… Pulse Biosciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks24th Percentile Overall ScorePLSE MarketRank™: Pulse Biosciences scored higher than 24% of companies evaluated by MarketBeat, and ranked 840th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Pulse Biosciences. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioPulse Biosciences has a P/B Ratio of 21.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Pulse Biosciences' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted18.71% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently decreased by 4.47%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPulse Biosciences does not currently pay a dividend.Dividend GrowthPulse Biosciences does not have a long track record of dividend growth. Sustainability and ESG4.2 / 5Environmental Score-0.60 Percentage of Shares Shorted18.71% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently decreased by 4.47%, indicating that investor sentiment is improving. News and Social Media2.1 / 5News Sentiment0.84 News SentimentPulse Biosciences has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Pulse Biosciences this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for PLSE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pulse Biosciences insiders have not sold or bought any company stock.Percentage Held by Insiders71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pulse Biosciences' insider trading history. Receive PLSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PLSE Stock News HeadlinesPulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual MeetingMay 2 at 1:29 AM | finance.yahoo.comPulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 25, 2025 | businesswire.comDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.May 3, 2025 | Weiss Ratings (Ad)Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its BusinessApril 24, 2025 | finance.yahoo.comPulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025April 24, 2025 | businesswire.comPulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual MeetingApril 23, 2025 | finance.yahoo.comPulse Biosciences: Some Key Questions Remain UnansweredApril 10, 2025 | seekingalpha.comPulse Biosciences: Interesting Product, But No Revenue StreamApril 10, 2025 | seekingalpha.comSee More Headlines PLSE Stock Analysis - Frequently Asked Questions How have PLSE shares performed this year? Pulse Biosciences' stock was trading at $17.41 on January 1st, 2025. Since then, PLSE shares have decreased by 1.3% and is now trading at $17.19. View the best growth stocks for 2025 here. How were Pulse Biosciences' earnings last quarter? Pulse Biosciences, Inc. (NASDAQ:PLSE) released its quarterly earnings data on Wednesday, October, 30th. The company reported ($0.21) earnings per share for the quarter. Read the conference call transcript. When did Pulse Biosciences IPO? Pulse Biosciences (PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO. Who are Pulse Biosciences' major shareholders? Pulse Biosciences' top institutional investors include Griffin Asset Management Inc. (0.35%), Westside Investment Management Inc. (0.09%), Rhumbline Advisers (0.04%) and China Universal Asset Management Co. Ltd. (0.02%). Insiders that own company stock include Robert W Duggan, Mitchell E Levinson, Mitchell E Levinson, Burke Thomas Barrett and Kevin Patrick Danahy. View institutional ownership trends. How do I buy shares of Pulse Biosciences? Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pulse Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL). Company Calendar Last Earnings10/30/2024Today5/03/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PLSE CIK1625101 Webwww.pulsebiosciences.com Phone(510) 906-4600FaxN/AEmployees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,210,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-96.89% Return on Assets-74.83% Debt Debt-to-Equity RatioN/A Current Ratio11.93 Quick Ratio11.93 Sales & Book Value Annual Sales$700,000.00 Price / Sales1,652.06 Cash FlowN/A Price / Cash FlowN/A Book Value$0.81 per share Price / Book21.22Miscellaneous Outstanding Shares67,274,000Free Float17,532,000Market Cap$1.16 billion OptionableOptionable Beta1.60 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:PLSE) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.